Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms, Male 2Breast Neoplasms 2Melanoma 1

Interventions

Cyclophosphamide 18Trastuzumab 16Paclitaxel 15Taxes 11Doxorubicin 11Radiotherapy 7Lapatinib 6Albumin-Bound Paclitaxel 6Vorinostat 5Tamoxifen 5Docetaxel 5Carboplatin 5Capecitabine 5Bevacizumab 5Radiation 4Letrozole 4Immunohistochemistry 4Anastrozole 4sargramostim 3pegfilgrastim 3exemestane 3Magnetic Resonance Spectroscopy 3Immunoenzyme Techniques 3Granulocyte-Macrophage Colony-Stimulating Factor 3Granulocyte Colony-Stimulating Factor 3Fluorodeoxyglucose F18 3Flow Cytometry 3Filgrastim 3Chemotherapy, Adjuvant 3saponin QA-21V1 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms, Male × saponin QA-21V1 × Clear all
NCT00470574 2020-11-18

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
7 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00030823 2015-12-30

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Memorial Sloan Kettering Cancer Center

Phase NA Completed
14 enrolled 6 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡